Microsoft Word - ELCID_Telemax Capital Increase No. FER 600195 March 23, 2018 Subject : Notification of the capital increase and investment plan of its subsidiary Attention : President, The
Baht 6,563,700. Refer to the purchase of the said shares to eliminate the conflict of interest under the Notification of Capital Market Supervisory Board No. Tor Jor 39/2559 shall increase the Company's
increase above, the Company’s shareholding in KTMS shall increase from 70.00 percent to 77.3 percent. The details of KTMS's shareholding structure are as follows: Shareholders Before capital increase After
% or THB 13,902mn from 31 December 2017, mostly from the EBT of UE, which was funded by a capital increase via issuance of preferred shares in the first quarter Net debt to equity ratio as of 31
shares. Page 2/19 As subscription of capital increase above, the Company’s shareholding in KTMS shall increase from 70.00 percent to 77.3 percent. The details of KTMS's shareholding structure are as
17.74% 20.03 9.21% 49.42 246.73% Jul – Sep 63 Jul – Sep 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขที่ 111 หมู่ที่ 2 ตาํบลท่าจนี อาํเภอเมืองสมุทรสาคร จงัหวดัสมุทรสาคร 74000 111 Moo 2
the same period of the year over year. Revenue from network marketing business was THB 71.63 Million having growth by 1,080.07% The revenue of each business unit which were shown above, didn’t eliminate
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
Increase Form (F 53-4) (Revised version) 2. The Preliminary Features of Warrants to Purchase Ordinary Shares of the Company No.3 (JMART-W3) (Revised version) 3. The Preliminary Features of Warrants to
Baht 0.40 and 0.83 respectively. The decreased loss is due to the major transactions as follow: 1. The increase of net earned premium in this quarter compared to the same period of last year in the